ApplePhenon® (Apple Polyphenol Extract — BGG)

Malus domestica
Evidence Level
Strong
2 Clinical Trials
6 Documented Benefits
4/5 Evidence Score

ApplePhenon® is BGG's proprietary apple polyphenol extract produced from wild unripe apple fruit (central Asia) - standardized to approximately 70% polyphenols with a unique phytochemical profile: 63.8% procyanidins (with characterized dimer-through-polymer fractions), 12.4% flavan-3-ols (catechin, epicatechin), 10.8% hydroxycinnamic acids (including chlorogenic acid), and 6.5% phloretin glucosides (including phloridzin). The clinical dose is 600 mg/day. Human RCTs show decreased visceral fat area, and significant decreases in total cholesterol and LDL plus increased adiponectin. ApplePhenon has also been studied in pediatric atopic dermatitis and UV-induced skin pigmentation. Honest framing: solid clinical evidence base built up over 15+ years; the visceral fat and LDL effects are modest but reproducible, useful as part of a broader metabolic support stack rather than a standalone weight loss intervention.

Studied Dose 600 mg/day (divided); 300 mg/day also studied; pigmentation trials 8 tablets/day.
Active Compound Apple (Malus domestica) polyphenol extract, ~70% total polyphenols (63.8% procyanidins, 12.4% flavan-3-ols, 10.8% hydroxycinnamic acids incl. chlorogenic acid, 6.5% phloretin glucosides incl. phloridzin).

Benefits

Visceral fat reduction (94-subject RCT)

600 mg/day for 8-12 weeks significantly decreased visceral fat area vs placebo, measured by computed tomography - the gold-standard methodology for visceral (intra-abdominal) fat assessment. Visceral fat is the metabolically harmful fat pad most associated with cardiometabolic risk.

Cholesterol improvement (71-subject RCT)

600 mg/day significantly decreased total cholesterol and LDL-cholesterol (-16.13 mg/dL) vs placebo, with effects more marked than a hop bract polyphenol comparator. Useful supplement-level addition for mild lipid management.

Adiponectin elevation

Documented increased adiponectin levels in the ApplePhenon group. Adiponectin is an anti-inflammatory adipokine that improves insulin sensitivity and is generally lower in obesity. Elevation via dietary polyphenols is a mechanistically meaningful metabolic effect.

Procyanidin oligomer enrichment

ApplePhenon's procyanidin profile is unusually rich in lower-degree oligomers (dimers through hexamers comprise ~43% of total procyanidins). Lower oligomers are more bioavailable than high-polymer procyanidins, which are essentially unabsorbed. This profile distinguishes ApplePhenon from grape seed or other procyanidin sources with predominantly high-polymer profiles.

Gut microbiome modulation (preclinical)

Preclinical studies show apple polyphenols decrease the Firmicutes/Bacteroidetes ratio (associated with metabolic dysfunction in obesity) and increase Akkermansia muciniphila by approximately 8-fold. Akkermansia is a 'next-generation probiotic' species associated with improved metabolic health, gut barrier integrity, and reduced inflammation. Human microbiome data with ApplePhenon are less detailed but mechanism is well-supported.

Skin pigmentation modulation

Demonstrated effects on UV-induced skin pigmentation in women using ApplePhenon tablets. The procyanidin and chlorogenic acid components have documented in vitro melanocyte and tyrosinase-modulating effects.

Mechanism of action

1

Pancreatic lipase inhibition

Apple procyanidins inhibit pancreatic lipase activity, reducing dietary fat absorption from the small intestine. This mechanism contributes to visceral fat reduction and partial cholesterol improvements through reduced dietary fat uptake — similar in kind (but milder) to orlistat.

2

AMPK activation and fatty acid synthase inhibition

Preclinical data demonstrate apple polyphenols activate AMP-activated protein kinase (AMPK) and decrease transcription of lipogenic genes — similar to caloric restriction effects. Reduces de novo fatty acid synthesis in liver and adipose tissue.

3

Gut microbiome modulation

Apple polyphenols reach the colon largely intact (high-polymer procyanidins) where they serve as substrate for beneficial bacteria. The 8-fold increase in Akkermansia muciniphila is mechanistically significant — this organism produces propionate and strengthens mucin barrier integrity, both contributing to metabolic and inflammatory benefits.

4

Antioxidant and SOD-like activity

Apple procyanidins and their oligomeric fractions have documented SOD-like (superoxide dismutase-like) activity — directly scavenging superoxide radicals. This direct antioxidant activity complements the broader polyphenol antioxidant mechanism via free radical scavenging.

Clinical trials

1
ApplePhenon Visceral Fat Trial — 94 Subjects

Randomized double-blind placebo-controlled trial in 94 subjects with BMI 25-30. Intervention: 600 mg/day ApplePhenon vs placebo for 8-12 weeks.

94 subjects with BMI 25-30

Randomized double-blind placebo-controlled trial in 94 subjects with BMI 25-30. Intervention: 600 mg/day ApplePhenon vs placebo for 8-12 weeks. Outcome: significant decrease in visceral fat area vs placebo. Establishes the clinical dose-response basis for the 600 mg/day protocol used in subsequent trials.

2
ApplePhenon Cholesterol & Body Composition — 71 Subjects

Three-arm randomized double-blind placebo-controlled trial in 71 moderately obese subjects (BMI 23-30). Arms: ApplePhenon 600 mg/day, hop bract polyphenol 600 mg/day, placebo.

71 moderately obese subjects

Three-arm randomized double-blind placebo-controlled trial in 71 moderately obese subjects (BMI 23-30). Arms: ApplePhenon 600 mg/day, hop bract polyphenol 600 mg/day, placebo. 12 weeks. Outcomes: ApplePhenon significantly decreased total cholesterol and LDL-cholesterol (LDL -16.13 mg/dL, p<0.05), decreased visceral fat area, and increased adiponectin vs placebo. Effects more marked than hop bract comparator. No adverse biochemical or hematological abnormalities.

Side effects and drug interactions

Common Potential side effects

Excellent tolerability; apple polyphenols are dietary constituents with established food-safety history.
NOAEL >2,000 mg/kg in toxicity studies — substantial safety margin.
No significant hematological, biochemical, or clinical adverse effects in 90-day subchronic toxicity studies.
Mild GI effects possible at very high doses.
Apple allergy contraindication (oral allergy syndrome with birch pollen cross-reactivity in some individuals).

Important Drug interactions

Diabetes medications — apple polyphenols may have mild glucose-lowering effects; monitor.
Statins — additive mild lipid-lowering effects; generally complementary.
Iron supplements — high polyphenol intake can modestly reduce iron absorption; separate timing if iron deficiency is a concern.
Pregnancy and lactation — apple polyphenols are dietary components; supplemental doses lack pregnancy-specific safety data, but no signal of harm from dietary apple intake.

Frequently asked questions about ApplePhenon® (Apple Polyphenol Extract — BGG)

What is ApplePhenon?

ApplePhenon® is BGG's proprietary apple polyphenol extract produced from wild unripe apple fruit (central Asia) - standardized to approximately 70% polyphenols with a unique phytochemical profile: 63.8% procyanidins (with characterized dimer-through-polymer fractions), 12.4% flavan-3-ols (catechin, epicatechin), 10.

What is ApplePhenon used for?

ApplePhenon is researched primarily for Weight Management, Cardiovascular, and Antioxidant. 600 mg/day for 8-12 weeks significantly decreased visceral fat area vs placebo, measured by computed tomography - the gold-standard methodology for visceral (intra-abdominal) fat assessment.

What is the recommended dosage of ApplePhenon?

The clinically studied dose is 600 mg/day (divided); 300 mg/day also studied; pigmentation trials 8 tablets/day. Always follow the product label and check with a healthcare provider for personal advice.

Is ApplePhenon safe, and does it have side effects?

For most healthy adults, ApplePhenon is well tolerated at studied doses. Reported effects can include: Excellent tolerability; apple polyphenols are dietary constituents with established food-safety history. NOAEL >2,000 mg/kg in toxicity studies — substantial safety margin. It may also interact with some medications. ApplePhenon is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does ApplePhenon interact with any medications?

Possible interactions include: Diabetes medications — apple polyphenols may have mild glucose-lowering effects; monitor. Statins — additive mild lipid-lowering effects; generally complementary. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for ApplePhenon?

NutraSmarts rates the evidence for ApplePhenon as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Ataka S, Tanaka M, Nozaki S, Mizuma H, Mizuno K, Tahara T, et al. Effects of Applephenon and ascorbic acid on physical fatigue Nutrition. 2007;23(5):419-23. doi: 10.1016/j.nut.2007.03.004.PubMedUsed to support: Brand-specific evidence for the exercise/anti-fatigue claim: Applephenon, the named apple-polyphenol extract, plus vitamin C reduced physical fatigue measures in a human study. Honesty: small early trial, the effect was modest, and the polyphenol was co-administered with ascorbic acid.
  2. Nagasako-Akazome Y, Kanda T, Ohtake Y, Shimasaki H, Kobayashi T Apple polyphenols influence cholesterol metabolism in healthy subjects with relatively high body mass index J Oleo Sci. 2007;56(8):417-28. doi: 10.5650/jos.56.417.PubMedUsed to support: Backs the lipid/metabolic claim: apple polyphenols lowered total and LDL cholesterol in higher-BMI adults. Honesty: small Japanese trial using apple polyphenol extract (the Applephenon class of material) with modest effect sizes.
  3. Akazome Y, Kametani N, Kanda T, Shimasaki H, Kobayashi S Evaluation of safety of excessive intake and efficacy of long-term intake of beverages containing apple polyphenols J Oleo Sci. 2010;59(6):321-38. doi: 10.5650/jos.59.321.PubMedUsed to support: Supports the visceral-fat/metabolic and safety claims: long-term apple-polyphenol intake was well tolerated and associated with reductions in visceral fat and body weight. Honesty: manufacturer-associated Japanese study with modest effects, testing apple-polyphenol material generally rather than a specific disease endpoint.
  4. Kishi K, Saito M, Saito T, Kumemura M, Okamatsu H, Okita M, Takazawa K Clinical efficacy of apple polyphenol for treating cedar pollinosis Biosci Biotechnol Biochem. 2005;69(4):829-32. doi: 10.1271/bbb.69.829.PubMedUsed to support: Backs the allergic-rhinitis (Japanese cedar pollinosis) claim: apple polyphenol reduced sneezing and nasal symptoms vs placebo. Honesty: small seasonal-allergy RCT in a Japanese cohort using apple polyphenol extract, with modest symptom relief.